Release Date: April 29, 2025
Expiration Date: April 29, 2026
Activity Overview
This educational activity is designed to provide expert perspectives on data presented in early 2025 regarding the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). As part of a panel discussion, 2 expert faculty members share their insights on the relevance of these findings on patient management decisions.
Target Audience
This online educational activity is directed toward retina specialists, ophthalmologists, and optometrists.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize emerging evidence regarding the treatment of retinal diseases as presented at major medical conferences in 2025
- Recognize patient populations who may benefit from evidence-based therapies used in the management of nAMD based on patient presentation and treatment goals
- Identify appropriate patient populations who may benefit from evidence-based therapies used in the management of DME based on clinical presentation and goals of treatment
- Utilize evidence regarding advanced dosing strategies into individualized treatment for patients with DME
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
